Mapping the Translational Potential of Injectable Natural-Product Drug-Delivery Systems for Osteoarthritis Toward Pharmacopuncture: A Scoping Review Protocol
Journal of Acupuncture Research · 16.11.2026 · 43
DOI: 10.13045/jar.26.0050 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Acupuncture Research, online erschienen am 16.11.2026. Verfasst von Ae Jin Song und 1 weiteren Autor:innen. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Background
Osteoarthritis (OA) management remains largely symptomatic, and natural products with anti-inflammatory and chondroprotective activity are limited in practice by poor joint retention and bioavailability. Pharmacopuncture, a Korean medicine treatment that injects herbal or natural-product-derived agents at acupoints or lesion sites, including the joint cavity, is a potential local delivery route, but its drug-delivery properties have not been systematically evaluated. Coupling drug-delivery system (DDS) technology with pharmacopuncture may extend joint retention and control release, yet this preclinical evidence base has not been mapped.
Methods
This article reports the protocol and translational classification framework of a scoping review of preclinical studies on injectable, intra-articular, natural-product-based DDS for OA. The review followed the Joanna Briggs Institute methodology and is reported according to PRISMA-ScR. Three databases were searched on April 7, 2026. Eligible studies used an OA model (animal, in vitro, or ex vivo) and a natural product formulated within a DDS; in vivo studies also required confirmed intra-articular administration. Screening, eligibility assessment, and data extraction were each performed independently by two reviewers, with disagreements resolved by consensus. We developed a three-tier pharmacopuncture-applicability classification (Very High/High/Moderate) based on injectability, intra-articular administration, and demonstrated delivery performance.
Results
Of the 667 records identified, 33 studies met all eligibility criteria after title/abstract screening and full-text assessment.
Conclusion
This protocol provides a reproducible framework, including a novel translational applicability tier system, for mapping how injectable natural product DDS research for OA can inform pharmacopuncture formulation development. The findings are reported in a companion article.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
Zitieren
APA
Song, A. J., & Song, H. S. (2026). Mapping the Translational Potential of Injectable Natural-Product Drug-Delivery Systems for Osteoarthritis Toward Pharmacopuncture: A Scoping Review Protocol. Journal of Acupuncture Research, 43. https://doi.org/10.13045/jar.26.0050
Vancouver
Song AJ, Song HS. Mapping the Translational Potential of Injectable Natural-Product Drug-Delivery Systems for Osteoarthritis Toward Pharmacopuncture: A Scoping Review Protocol. Journal of Acupuncture Research. 2026;43. doi:10.13045/jar.26.0050
BibTeX
@article{Song2026,
author = {Song, Ae Jin and Song, Ho Sueb},
title = {Mapping the Translational Potential of Injectable Natural-Product Drug-Delivery Systems for Osteoarthritis Toward Pharmacopuncture: A Scoping Review Protocol},
journal = {Journal of Acupuncture Research},
year = {2026},
volume = {43},
doi = {10.13045/jar.26.0050}
}
EUVIMED